NewGenIvf (NIVF) Profit After Tax (2024 - 2025)

NewGenIvf (NIVF) reported Profit After Tax of -$7.7 million for Q4 2025, down 7099.51% year-over-year from $109563.6 in Q4 2024, and down 145.58% quarter-over-quarter from $16.8 million in Q3 2025.

NewGenIvf (NIVF) Profit After Tax (2024 - 2025) Analysis & Trends

NewGenIvf (NIVF) has 2 years of Profit After Tax data on file, last reported at -$7.7 million in Q4 2025.

  • Profit After Tax for Q4 2025 came in at -$7.7 million, down 7099.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.0 million (changed N/A YoY), and the FY2025 annual result was $9.9 million, up 1983.07% from the prior year.
  • Profit After Tax eased to -$7.7 million in Q4 2025 per NIVF's latest filing, from $16.8 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $16.8 million in Q3 2025 and troughed at -$7.7 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn 1.86 Bn
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn 906.00 Mn
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn 197.53 Mn
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn 248.20 Mn
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn 99.67 Mn
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn 348.68 Mn
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn 1.14 Mn
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn 66.30 Mn
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn 80.70 Mn
10 NewGenIvf - - 524,025.00 -7.67 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.67 Mn
Sep 30, 2025 16.82 Mn
Dec 31, 2024 -106,520.00
Sep 30, 2024 -21,580.00